L7 ESP v.2.0 expands platform functionality to support complex “bench-to-bedside” life science industry and regulatory requirements
AUSTIN, Texas, Oct. 10, 2018 — L7 Informatics, Inc., formerly Lab7 Systems, a leader in informatics solutions and services for data intensive scientific applications and personalized medicine, is pleased to announce today the release of Enterprise Science Platform 2.0 (ESP) with a validated pre-built Microsoft Azure connector to the Microsoft Genomics service on the Azure cloud.
The upcoming ESP 2.0 release has a number of new modules and enhancements, including but not limited to:
- Workflow Chaining, supporting the execution of sophisticated processes, such as conditional process execution/branching, repeats, and other intelligent, multi-variable process requirements
- New UI, with emphasizing increased responsiveness and an improved user experience
- Improved integration of Software Development Kit capabilities (SDK) as well as new extension and customizability options along
- Content support for next-generation sequencing, translational research, and cell therapy applications
- Validation of ESP on the Azure platform, enabling the management of and running bioinformatics pipelines on Microsoft Genomics cloud
ESP 2.0 marks a major milestone for L7. With this release, ESP can now support a wide range of life science companies: from the venture-backed cell therapy company, established laboratories and research clinics, to the largest of the global biotechnology and pharmaceutical companies. All these companies share a common need: a highly adaptive “bench-to-bedside” technology platform to eliminate processing and technological silos.
“L7 has worked tirelessly since last May, when we announced our partnership with Microsoft Genomics. We have focused our attention to empower our mutual customers to easily implement our integrated and validated offering,” commented Vasu Rangadass, Ph.D., L7 Informatics’ CEO. “Our partnership with Microsoft shows their confidence in L7’s ability to deliver. We are humbled by Microsoft’s trust.”
L7 Informatics and Microsoft are presenting the latest enhancements to the ESP + Microsoft Genomics platforms at the 2018 American Society of Human Genetics (ASHG) Conference in San Diego, CA (October 16-20, 2018). L7 Informatics will also host a demo at the Microsoft booth (#1535) on Thursday, October 18th at 11:30 am. L7 team members will be readily available to answer questions.
“We’re very excited about our partnership with L7 because they appreciate and align their product and commercialization strategy with the market landscape of precision medicine and multi-omics opportunities,” mentioned Trent Norris, Senior Program Manager, Microsoft Genomics. “When markets move at this speed, companies must be agile and take calculated risks in order to drive innovation that leads to sustained growth. L7 is reshaping the way companies should think about laboratory information management systems and we’re pleased that they chose to do it on Azure and with the Microsoft Genomics service.”
About L7 Informatics
L7 Informatics, formerly Lab7 Systems, provides software and services that enable synchronized solutions for science and health. L7’s Enterprise Science Platform (ESP) is a scientific information management (SIM) solution that enables life science and healthcare companies to connect people, processes, and systems to accelerate discoveries and drive precision healthcare. Global, venture-funded and public health organizations such as Astra Zeneca, Gradalis, and USDA trust L7’s ESP. For more information, visit www.l7informatics.com.
Speaks Marketing Group
SOURCE: L7 Informatics, Inc.